RNF213 and infection: In addition, RNF213 has been demonstrated to restrict the de novo infection and lytic reactivation of Kaposi’s sarcoma-associated herpesvirus (KSHV) by degrading Replication and Transcription Activator (RTA) through the ubiquitin–proteasome pathway [17].